A research laboratory dedicated to congenital metabolic diseases research has been formed by Karolinska Institutet and Max Planck Society.
The new Max Planck Institute for Biology of Ageing — Karolinska Institutet Laboratory is to be established in the department of laboratory medicine on Karolinska Institutet’s Solna campus.
At the Max Planck Institute, this research has mostly been carried out using animal models, but the new laboratory at Karolinska Institutet will offer fresh opportunities to collaborate using the unique patient material to which Karolinska Institutet’s scientists have access.
“Even if we’ll be collaborating on a small scale at first, it’s important to both parties,” says Hans-Gustaf Ljunggren, dean of research at Karolinska Institutet. “Together, we’ll advance our research in a way that would have been impossible had we been working alone.”
The collaborative programme will run for five years under with researchers recruited from Karolinska Institutet in Stockholm and visiting researchers from the Max Planck Institute in Cologne. There is also provision in the programme for doctoral students and postdocs to join as visiting researchers.